- Komel T, Bosnjak M, Kranjc Brezar S, De Robertis M, Mastrodonato M, Scillitani G, Pesole G, Signori E, Sersa G, Cemazar M. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma. Bioelectrochemistry 2021 Oct;141:107843
- Jean Carlos dos Santos da Luz, Fernanda Antunes, Maria Alejandra Clavijo-Salomon, Emanuela Signori, Nayara Gusmão Tessarollo, and Bryan E. Strauss. Clinical Applications and Immunological Aspects of Electroporation-Based Therapies. Vaccines 2021, 9(7): 727
- Cancelliere R, Di Tinno A, Di Lellis, AM, Tedeschi Y, Bellucci S, Carbone K, Signori, E, Contini G, Micheli L. An inverse-designed electrochemical platform for analytical applications. Electrochemistry Communications 2020, 121,106862
- De Robertis M, Mazza T, Fusilli C, Loiacono L, Poeta ML, Sanchez M, Massi E, Lamorte G, Diodoro MG, Pescarmona E, Signori E, Pesole G, Vescovi AL, Garcia-Foncillas G and Fazio VM. EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers. Molecular Cancer 2018, 17:169
- Marino M, Olaiz N, Signori E, Maglietti F, Suarez C, Michinski S, Marshall G. pH fronts and tissue natural buffer interaction in gene electrotransfer protocols. Electrochimica Acta 2017, Nov 20; 255:463-471
- De Robertis M., Loiacono L., Fusilli C Poeta ML, Mazza T, Sanchez M, Marchionni L, Signori E, Lamorte G, Vescovi AL, Garcia-Foncillas J, Fazio VM. Dysregulation of EGFR pathway in EphA2 cell subpopulation significantly associates with poor prognosis in colorectal cancer. Clin Cancer Res. 2017 Jan 1;23(1):159-17
- Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, Miklavcic D. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother. 2015, 64(10): 1315-1327
- Block KI, Gyllenhaal C, Lowe L, …, Signori E, et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment Semin Cancer Biol. 2015 Dec; 35S:S276-S304
- Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HM, Signori E, et al. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015 Mar 25. pii: S1044-579
- Olaiz N*, Signori E*, Maglietti F, Soba A, Suarez C, Turjanski P, Michinski S, Marshall G. Tissue damage modeling in gene electrotransfer: The role of pH. Bioelectrochemistry 2014, 100:105-111. *Equal Contribution
- Lucá R, Averna M, Zalfa F, Vecchi M, Bianchi F, Fata GL, Del Nonno F, Nardacci R, Bianchi M, Nuciforo P, Munck S, Parrella P, Moura R, Signori E, et al. The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med. 2013 Oct;5(10):1523-1536
- Chiarella P, Summa V, De Santis S, Signori E, et al. Bcr/Abl1 fusion transcripts generated from alternative splicing: implications for future targeted therapies in Ph+leukaemias. Current Molecular Medicine, 2012 Jun 1;12(5):547-65
- Bordignon V, Cordiali-Fei P, Rinaldi M, Signori E, et al. Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma model. J Exp Clin Cancer Res.2012 Feb 1;31(1):9
- De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog.2011 Mar 24;10:9
- Nicolò C, Sali M, Di Sante G, Geloso MC, Signori E, et al. Mycobacterium smegmatis expressing a chimeric protein MPT64-PLP139-151 reorganizes the PLP-specific T cell repertoire favouring a CD8-mediated response and induces a relapsing EAE. Immunol, 2010, Jan 1;184(1):222-35
- Cervelli M, Fratini E, Amendola R, Bianchi M, Signori E, et al. Increased spermine oxidase (SMO) activity as a novel differentiation marker of myogenic C2C12 cells. J. Biochem. Cell. Biol. 2009, 41(4):934-944
- Volpe G, Cignetti A, Panuzzo C, Kuka M, Vitaggio K, Brancaccio L, Perrone G, Rinaldi M, Prato G, Fava M, Geuna M, Pautasso M, Casnici C, Signori E, et al. Alternative BCR/ABL splice variants in Philadelphia chromosome positive leukemias result in novel tumor specific fusion proteins that may represent potential targets for immunotherapy approaches. Cancer Research 2007, 67(11): 5300-5307
- Rinaldi M, Signori E, et al. Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety. Vaccine2006, 24(21):4586-91
- Signori E, et al. A mutation in the 5’ UTR of BRCA1 gene, causes a down modulation of translation efficiency in a sporadic breast cancer. Oncogene 2001, 20(33):4596-4600
- McMahon JM, *Signori E, et al Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage. Gene Therapy, 2001, 8(16): 1264-1270,*Equal contribution
- Rinaldi M, Ria F, Parrella P, Signori E, et al. Antibodies elicited by naked DNA vaccination against hypevariable VH-CDR3 idiotypic determinants of B-lymphoproliferative disorders specifically react with patient's tumor cells. Cancer Research, 2001, 61: 1555-1562
- Rinaldi M,Barrera G, Spinsanti P, Pizzimenti S, Ciafrè SA, Parrella P, Farace MG, Signori E, et al. Growth inhibition and differentiation induction in murine erythroleukemia cells by 4-hydroxynonenal. Free Radical Res. 2001, 34(6): 629-637
- Rinaldi M, Ria F, Parrella P, Signori E, et al. Antibodies elicited by naked DNA vaccination against hypevariable VH-CDR3 idiotypic determinants of B-lymphoproliferative disorders specifically react with patient's tumor cells. Cancer Research, 2001, 61: 1555-1562
- Rinaldi M, Catapano AL, Parrella P, Ciafre SA, Signori E, Seripa D, Uboldi P, Antonini R, Ricci G, Farace MG, Fazio VM. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA. Gene Ther., 2000, 7: 1795-801.
- Papa S, Rinaldi M, Mangia A, Parrella P, Signori E, Lombardi L and Fazio VM. Development of a multigenic plasmid vector for HCV DNA-immunization. Virol., 1998, 149: 315-319.
- Rinaldi M, Ciafrè SA, Parrella P, Signori E,Farace MG. Saglio G, and Fazio VM Strategies to elicit anti-idiotypic immune response in B-lymphoma patients: peptide and genetic immunizzation. Exp. Med. Biol., 1998, 451: 323-330.
- Ciafrè SA, Rinaldi M, Vespignani I, Parrella P, Seripa D, Signori E, Ria F, Farace MG and Fazio VM. A plasmid family containing two different expression cassettes suitable for immuno-modulation and genetic immunization. Plasmid, 1998, 40(1): 84-89.